Pharmaceuticals company RPG Life Sciences announced Q2FY26 results Revenue from Operations: Rs 181.7 crore compared to Rs 168.9 crore during Q1FY26, change 7.6%. EBITDA: Rs 43.6 crore compared to Rs 40.7 crore during Q1FY26, change 7.1%. EBITDA Margin: 24.0% for Q2FY26. PBT: Rs 38.2 crore compared to Rs 35.4 crore during Q1FY26, change 7.9%. PAT: Rs 28.5 crore compared to Rs 26.3 crore during Q1FY26, change 8.1%. PAT Margin: 15.7% for Q2FY26. Result PDF